Sleep Disturbances in the Elderly

Initial Assessment and Treatment

The American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment for elderly patients with sleep disturbances, and pharmacotherapy should only be considered when CBT-I has failed, using ramelteon or low-dose doxepin as preferred agents over benzodiazepines or Z-drugs 1, 2
Before initiating any treatment, evaluate specific factors including medication review to identify drugs that disrupt sleep, such as β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, SSRIs, and SNRIs 1, 2
Screen for primary sleep disorders, including obstructive sleep apnea (24% prevalence), restless legs syndrome (12% prevalence), and periodic limb movements (45% prevalence) 2
Assess for sleep-impairing behaviors, such as excessive daytime napping, prolonged time in bed, insufficient physical activity, evening alcohol consumption, late heavy meals, and environmental factors (room temperature, noise, light) 1, 3
Identify medical comorbidities, such as pain, nocturia, gastroesophageal reflux, and neurodegenerative disorders that exacerbate sleep disruption 2

CBT-I is the gold standard initial treatment with proven efficacy and sustained effects for up to 2 years, superior to medications in long-term outcomes, as recommended by the American College of Physicians and American Geriatrics Society 1, 2, 4
Core CBT-I components include sleep restriction/compression therapy, stimulus control, sleep hygiene, and relaxation techniques, such as progressive muscle relaxation, guided imagery, and diaphragmatic breathing 1, 3
Physical and social activities may increase total nocturnal sleep time and sleep efficiency 5, 6
Bright light therapy can be used for circadian rhythm disorders, with 2500-5000 lux for 1-2 hours between 09:00-11:00 6, 4

Pharmacotherapy should only be initiated after CBT-I has been attempted or when combined with ongoing behavioral interventions, starting at the lowest available dose due to reduced drug clearance and increased sensitivity in elderly patients 1, 4
Preferred first-line medications include ramelteon 8 mg for sleep-onset insomnia and low-dose doxepin 3-6 mg for sleep-maintenance insomnia, with eszopiclone 1-2 mg and zolpidem extended-release 6.25 mg as alternative options 1, 2, 4
Medications to avoid include benzodiazepines, diphenhydramine, and antihistamines due to increased risk of falls, cognitive impairment, and adverse events 1, 2, 4, 7

For nursing home residents, multicomponent interventions combining increased daytime physical activity, sunlight exposure, decreased time in bed during day, bedtime routine, and decreased nighttime noise/light show modest benefits, as recommended by the American Medical Directors Association 7, 5, 8
For patients with dementia, light therapy is preferred over pharmacotherapy for irregular sleep-wake rhythm disorder, and hypnotic medications should be avoided due to increased risk of falls and adverse events 4, 7, 9

Never use sleep hygiene education alone as it is insufficient for chronic insomnia; must be combined with other CBT-I components 1
Avoid long-term pharmacotherapy without concurrent CBT-I trials whenever possible 1
Do not prescribe temazepam or diphenhydramine as they cause poor neurologic function and daytime hypersomnolence in nursing home residents 7, 5
Recognize that zolpidem carries significant risks, including cognitive impairment, memory problems, and increased mortality signals 4

The American Geriatrics Society recommends exercise and physical activities, such as stationary bicycle and Tai Chi, to improve sleep in elderly patients, particularly in nursing home settings 10
Combination of daily social and physical activity can increase slow wave sleep and improve memory-oriented tasks in elderly patients 10

The American Academy of Sleep Medicine provides a WEAK AGAINST recommendation for melatonin in dementia patients due to lack of efficacy in improving total sleep time and potential detrimental effects on mood and daytime functioning 10
Diphenhydramine and antihistamines, including Tylenol PM, should be strictly avoided in elderly patients due to poor neurologic function, daytime hypersomnolence, and anticholinergic effects 10

The American Geriatrics Society recommends increasing daytime physical activity and sunlight exposure to help regulate circadian rhythms in elderly nursing home residents 11
The American Geriatrics Society suggests decreasing time in bed during the day and discouraging daytime napping to consolidate nighttime sleep in elderly nursing home residents 11
The American Geriatrics Society recommends reducing nighttime noise and light interruptions to improve sleep quality in elderly nursing home residents 11

The American Academy of Sleep Medicine recommends a starting dose of 3 mg immediate-release melatonin at bedtime for REM sleep behavior disorder, which can be titrated up in 3-mg increments to 15 mg if needed 12
Melatonin works through circadian mechanisms, binding to M1 and M2 receptors to suppress REM sleep motor tone and renormalize circadian features of REM sleep, with effects persisting for several days after discontinuation 12

The American Geriatrics Society advises against using melatonin as first-line therapy without attempting non-pharmacological interventions, particularly in nursing home settings 11
Underlying medical causes of sleep disturbance, including pain, nocturia, gastroesophageal reflux, medications, and neurodegenerative disorders, should not be ignored in elderly nursing home residents 11, 13